JSP
Jackson Square Partners’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-134,927
| Closed | -$24.9M | – | 56 |
|
2024
Q4 | $24.9M | Sell |
134,927
-26,998
| -17% | -$4.98M | 2.59% | 12 |
|
2024
Q3 | $31.9M | Sell |
161,925
-16,301
| -9% | -$3.21M | 2.75% | 14 |
|
2024
Q2 | $36.8M | Sell |
178,226
-73,082
| -29% | -$15.1M | 2.25% | 22 |
|
2024
Q1 | $68.1M | Sell |
251,308
-98,183
| -28% | -$26.6M | 2.83% | 13 |
|
2023
Q4 | $82.6M | Buy |
349,491
+80,873
| +30% | +$19.1M | 2.68% | 17 |
|
2023
Q3 | $52.6M | Sell |
268,618
-322,623
| -55% | -$63.2M | 1.76% | 27 |
|
2023
Q2 | $124M | Sell |
591,241
-312,726
| -35% | -$65.8M | 3.63% | 8 |
|
2023
Q1 | $182M | Buy |
903,967
+42,844
| +5% | +$8.65M | 4.93% | 5 |
|
2022
Q4 | $188M | Sell |
861,123
-9,665
| -1% | -$2.11M | 5% | 3 |
|
2022
Q3 | $171M | Buy |
870,788
+435,318
| +100% | +$85.7M | 4.49% | 3 |
|
2022
Q2 | $93.2M | Buy |
435,470
+434,809
| +65,780% | +$93M | 2.18% | 22 |
|
2022
Q1 | $187K | Buy |
+661
| New | +$187K | ﹤0.01% | 93 |
|